ライフサイエンスコーパス: total pancreatectomy

1 from 7.3% (distal pancreatectomy) to 22.9% (total pancreatectomy).

2 e criteria underwent PD (47 head only and 10 total pancreatectomy).

3 duodenectomies, 4 distal pencreatectomies, 7 total pancreatectomies).

4 nts had Whipple procedure and 7 patients had total pancreatectomy.

5 ccessful islet isolation after near-total or total pancreatectomy.

6 it may play a role in diabetes secondary to total pancreatectomy.

7 endoscopic or surgical means, and partial or total pancreatectomy.

8 IK and an IK in place for 3 months underwent total pancreatectomy.

9 ic head were treated by regional subtotal or total pancreatectomy.

10 ent pancreaticoduodenectomies, 15% underwent total pancreatectomies, 10% underwent distal pancreatect

11 Two patients had total pancreatectomy, 2 had distal pancreatectomy, and t

12 n and 5-year survival were good for standard total pancreatectomies (28.6 months and 24.3%, respectiv

13 , three animals bearing TIK and IK underwent total pancreatectomy 3 months following islet transplant

14 eatectomy (13), pancreatic enucleation (10), total pancreatectomy (5), Appleby resection (4), and Fre

15 ile operative morbidity was higher following total pancreatectomy (69.0% vs. 38.6% for pancreaticoduo

16 A similar proportion of total pancreatectomy (74.7%) and pancreaticoduodenectomy

17 fter partial pancreatectomy (18/27; 67%) and total pancreatectomy (8/13; 62%) and occurred within 3 y

18 allogeneic islet transplantation as well as total pancreatectomy alone (nontransplanted group).

19 ections reflect the invasiveness of extended total pancreatectomies and the underlying advanced malig

20 onic pancreatitis recipients 1-8 years after total pancreatectomy and autoislet transplantation.

21 analyze factors predicting outcomes after a total pancreatectomy and islet autotransplantation (TP-I

22 ue, complications, and long-term outcomes of total pancreatectomy and islet autotransplantation (TP-I

23 Total pancreatectomy and islet autotransplantation is an

24 Total pancreatectomy and islet autotransplantation provi

25 Total pancreatectomy and islet cell autotransplantation

26 Total pancreatectomy and large regional excisions did no

27 Total pancreatectomy and marginal mass islet autotranspl

28 Total pancreatectomy and pancreaticoduodenectomy patient

29 with chronic pancreatitis who had undergone total pancreatectomy and successful intrahepatic islet a

30 ent an operation (6 distal pancreatectomy, 4 total pancreatectomy, and 4 pancreaticoduodenectomy); al

31 atient was unresectable, 6 (10%) underwent a total pancreatectomy, and 56 (89%) had a partial pancrea

32 esected via pancreaticoduodenectomy, 22% via total pancreatectomy, and 8% via distal pancreatectomy.

33 ntraperitoneal [IP] group, n = 9), following total pancreatectomy, and compared them with the respons

34 xide (DZX), and nine of whom required a near-total pancreatectomy, and one partial pancreatectomy.

35 ransplantation; (4) improving outcomes after total pancreatectomy; and (5) registry considerations fo

36 etion or left pancreatectomy, as indicated); total pancreatectomy as an alternative to high-risk anas

37 d glucose and HbA1c for up to 13 years after total pancreatectomy as treatment for chronic painful pa

38 unction was determined in 173 patients after total pancreatectomy at our center.

39 27; P < .001) and operative characteristics (total pancreatectomy: coefficient, 12 742.31; 95% CI, 10

40 A total of 434 consecutive total pancreatectomies for primary pancreatic or periamp

41 Total pancreatectomy for presumed painful chronic pancre

42 lycemia in patients undergoing near-total or total pancreatectomy for severe chronic pancreatitis.

43 ctomy, 2 with central pancreatectomy, 1 with total pancreatectomy) for failure to progress (14) and b

44 r in the Whipple procedure group than in the total pancreatectomy group (median survival 19 months vs

45 Four of six patients with total pancreatectomy had islet yields exceeding 5000 isl

46 The role of total pancreatectomy has historically been limited due t

47 prevention of diabetes in patients requiring total pancreatectomy if the pancreas is not extensively

48 Standard total pancreatectomy, if needed, is associated with good

49 odenectomy was performed in 71% of patients, total pancreatectomy in 15%, distal pancreatectomy in 12

50 Sequelae are from diabetes, provided total pancreatectomy is avoided.

51 After total pancreatectomy, islets were isolated by using a tw

52 Total pancreatectomy may be required in locally advanced

53 etween 1970 and 2007, patients who underwent total pancreatectomy (n = 100) or pancreaticoduodenectom

54 n follow-up, 37 months); none recurred after total pancreatectomy (n = 13; median follow-up, 32 month

55 her pancreatoduodenal resection (n = 103) or total pancreatectomy (n = 2).

56 ), distal pancreatectomy (n = 62; 10.6%), or total pancreatectomy (n = 7; 1.2%).

57 aged 4-6 months, underwent partial (n=4), or total pancreatectomy (n=11), and transplantation of auto

58 = 77 (75%)], tail resections [n = 16 (15%)], total pancreatectomies [n = 5 (5%)], and segment resecti

59 tients had tumor resection (19 Whipple, four total pancreatectomy, one distal pancreatectomy).

60 However, total pancreatectomy operative mortality decreased over

61 the complexities of chronic pancreatitis and total pancreatectomy outcomes and postsurgical diabetes

62 Total pancreatectomy patients had larger median tumor si

63 Total pancreatectomy patients had more lymph nodes harve

64 Total pancreatectomy perioperative mortality dramaticall

65 ticoduodenectomy, distal pancreatectomy, and total pancreatectomy, remain the only potentially curati

66 ibuted to restoration of normoglycemia, near-total pancreatectomy resulted in hyperglycemia, suggesti

67 Total pancreatectomy should be performed when oncologica

68 ncreatectomy to isolate autologous islets or total pancreatectomy to isolate minor antigen-mismatched

69 Total pancreatectomy (TP) removes the source of the pain

70 Long-term survival following total pancreatectomy versus pancreaticoduodenectomy was

71 ositive resection margins (22.2% vs. 43.7%) (total pancreatectomy vs. pancreaticoduodenectomy, respec

72 ) and perineural invasion (90.7% vs. 91.8%) (total pancreatectomy vs. pancreaticoduodenectomy, respec

73 Total pancreatectomy was associated with higher 30-day m

74 Total pancreatectomy was associated with peptic ulcerati

75 Total pancreatectomy was increasingly used over time (19

76 Extended total pancreatectomies were performed in 54% of cases, w

77 Four patients who developed diabetes after total pancreatectomy were candidates for the autologous

78 Total pancreatectomy with islet autotransplantation (TP-

79 tive pain but has not been widely applied to total pancreatectomy with islet autotransplantation (TPI

80 ocused on research gaps and opportunities in total pancreatectomy with islet autotransplantation (TPI

81 The patient underwent total pancreatectomy with splenectomy.